Cannabis firm Rua Bioscience targets October NZX listing

Cannabis firm Rua Bioscience targets October NZX listing
Brent Melville
Medicinal cannabis firm Rua Bioscience has signalled it will head to the NZX this October, breaking an initial public offering drought that has persisted since Napier Port listed in August last year.Chair Trevor Burt said the East Coast-based cannabis company, one of the first in New Zealand to be licensed for commercial production, is aiming for an IPO in the latter part of the year, “subject to market conditions and other company developments.”He said while the number of shares and price range are “yet to be decided,&rd...

More Markets

Why Fonterra wants to churn out more butter
Primary Sector

Why Fonterra wants to churn out more butter

Other dairy processors have also invested in it.

Fletcher Building MD: ‘It hurts to make these cuts’
Property

Fletcher Building MD: ‘It hurts to make these cuts’

An emotional Andrew Reding says staff understand why the firm has to cut back.

Steel & Tube and Michael Hill navigate economic headwinds
Markets

Steel & Tube and Michael Hill navigate economic headwinds

Steel & Tube says recovery could take another 12 to 18 months. 

Kiwibank eyes a fairer fight with the Aussie big four
Finance

Kiwibank eyes a fairer fight with the Aussie big four

Kiwibank, partway through a $500m capital hike, sells growth and culture stories.